Vertebral Technologies announced a successful outcome in the first lumbar fusion procedure in Mexico using the InterFuse® laterally-expandable device.
Orthocell entered into a research collaboration agreement with DePuy Synthes Products for the Ortho-ATI® stem cell treatment for tendon and ligament regeneration.Â
Results from Phase I and Phase II study indicate that Histogenics’ NeoCart® tissue-engineered implant is a safe, effective treatment for articular cartilage lesions through 5-year follow-up.
OssDsign entered into new commercial partnerships covering distribution of its products for cranial repair and facial bone reconstruction in Italy, Spain, Switzerland, Austria and The Netherlands.
Six new patents were granted to Spinal Simplicity in 2016, bringing its portfolio to 52 globally. A new Notice of Allowance in 2017 brings the company’s U.S. patent total to 16.
Strategic orthopaedic-related 510(k)s issued in December 2016 include: Envision 3D Image Guidance System (7D Surgical); Sphynx Anterolateral Plate (Eden Spine); Destiknee Total Knee (Meril Healthcare); Hubble II Lumbar Interbody Fusion System (Orbbo Surgical)
Cartiva secured US $8.5MM in a Series E financing. Proceeds will support commercialization of the Synthetic Cartilage Implant for treatment of great toe arthritis.
Johnson & Johnson Medical Devices, parent company to DePuy Synthes, announced CareAdvantage and Orthopaedic Episode of Care Approach services for healthcare systems.